Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer

Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. We report a case of unresectable treatment-naïve ATC showing a dramatic and durable response to first-line pembrolizuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabhan, Fadi, Kander, Elizabeth, Shen, Rulong, Agrawal, Amit, Sukrithan, Vineeth, Zhou, Ye, Goyal, Ashima, Roll, Katie, Shah, Manisha, Konda, Bhavana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166484/
https://www.ncbi.nlm.nih.gov/pubmed/34123437
http://dx.doi.org/10.1155/2021/5521649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166484/
https://www.ncbi.nlm.nih.gov/pubmed/34123437
http://dx.doi.org/10.1155/2021/5521649

Ejemplares similares